GlaxoSmithKline plc (GSK) - Investment Analysts' Weekly Ratings Changes
They now have a GBX 1,440 price target on the stock. 6/27/2016 - GlaxoSmithKline plc had its "neutral" rating reaffirmed by analysts at BNP Paribas.
from Biotech News
They now have a GBX 1,440 price target on the stock. 6/27/2016 - GlaxoSmithKline plc had its "neutral" rating reaffirmed by analysts at BNP Paribas.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments